Latest Contracts News

Corporate Travel Management Limited reported strong half-year results for the period ending December 31, 2024, with significant EBITDA growth and effective capital management, returning $52.3 million to shareholders. The company sets ambitious FY25 and FY26 targets focused on sustainable profit growth and market share expansion.

Corporate Travel Management Limited (CTM) reported a 42% drop in net profit for the half-year ended December 2024, amid a 6% revenue decline. Despite this, strong performances in North America and Australia & New Zealand, alongside ongoing automation and new client wins, position CTM for a rebound in the second half.

Iluka Resources reported a solid FY 2024 with $1.13 billion in mineral sands revenue and a net profit of $231 million, while advancing key projects like Balranald and Eneabba refinery.

Iluka Resources posted a solid 2024 performance with stable market conditions and sound margins despite inflationary pressures, while progressing key projects like Balranald and Eneabba.

Iluka Resources reported a 32% drop in net profit after tax to $231 million for 2024, while securing critical funding for its Eneabba rare earths refinery and progressing the Balranald mine development.

EBOS Group Limited announces the retirement of CEO John Cullity after a decade of strong growth, appointing Adam Hall as his successor to lead the company’s next phase of expansion.

EBOS Group Limited’s interim results for H1 2025 reveal a notable decrease in revenue and profit compared to the prior year, yet the company maintains its interim dividend, signaling confidence despite headwinds.

EBOS Group Limited posted robust interim results for H1 FY25, with underlying EBITDA rising 7.1% excluding the Chemist Warehouse Australia contract, driven by strong organic growth and strategic investments. The company maintained its dividend and reiterated FY25 EBITDA guidance between $575 million and $600 million.

EBOS Group Limited posted a strong half-year performance with underlying EBITDA up 7.1% to $291 million, driven by growth in healthcare and animal care segments, while maintaining its interim dividend amid the loss of the Chemist Warehouse contract.

EBOS Group Limited has reported a 9% drop in revenue and an 18.9% fall in net profit for the first half of fiscal 2025, yet it maintains its interim dividend at 57 NZ cents per share.

Fletcher Building reported a challenging HY25 with a 7% revenue decline and a net loss of NZ$134 million, while executing a $700 million equity raise to strengthen its balance sheet and advancing significant cost reduction initiatives.

Mineral Resources Limited reported a challenging FY25 half-year with a 9% revenue decline and a 55% drop in underlying EBITDA, yet its Mining Services segment and Onslow Iron project show promising growth trajectories.